Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Jiangsu Aidea Pharmaceutical Group Co., Ltd.

Clinical trials sponsored by Jiangsu Aidea Pharmaceutical Group Co., Ltd., explained in plain language.

Trials to join now! 1 Not yet finished but already full! 1

New HIV drug candidate targets resistant strains

Disease control Ongoing

This study tests a new drug called ACC017 in adults with HIV that has become resistant to standard treatments. The trial aims to see if ACC017 can lower the amount of virus in the blood to undetectable levels. Participants receive either ACC017 or a placebo for two weeks, followe…

Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Aidea Pharmaceutical Group Co., Ltd. • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC